On August 31, 2022 AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, reported that members of its senior management team are scheduled to participate in three investor conferences in September, including (Press release, AVEO, AUG 31, 2022, View Source [SID1234618829]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2022 Wells Fargo Healthcare Conference
Date: Wednesday – Friday, September 7th – 9th
Format: 1×1 Investor Meetings

H.C. Wainwright 24th Annual Global Investment Conference
Date: Monday, September 12th at 5:00 p.m. Eastern Time
Format: Fireside Chat and 1×1 Investor Meetings
Details: A live webcast of the H.C. Wainwright fireside chat can be accessed by visiting the investors section of the Company’s website at www.aveooncology.com. A replay of the webcast will be archived for 90 days following the presentation date.

Baird 2022 Global Healthcare Conference
Date: Tuesday, September 13th at 11:25 a.m. Eastern Time
Format: Presentation and 1×1 Investor Meetings